fda warning letters compounding semaglutide october 2025 Week Ending October 31, 2025: Featuring a Panel of FDA Compliance Leaders Discussing Key Current Concerns Hims and Hers warns investors

Biol Pharm Bull 2007;30(11):2007-2011

Stay active, energized, and maintain healthy weight management throughout the day.

[9]L-Citrulline and Arterial Stiffness PubMed View source For someone using amino acids specifically for cardiovascular support, L-arginine has more trial data to point to though the evidence is promising for citrulline as well

(iii) Discontinuation and washout: For semaglutide, product labeling advises discontinuation at least 2 months before a planned pregnancy (135, 153)

Combination therapy should only be reviewed by a licensed provider because dosing, monitoring, and safety risks become more complex

2023 Jan 11;28(2):751